Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Retained Gastric Contents During Esophagogastroduodenoscopy: A Propensity Score‐Matched Study
Digestive Endoscopy · 2025
DOI: 10.1111/den.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Endoscopy, 2025. Verfasst von Hiroyuki Hisada und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Endoscopy, Digestive System, Glucagon-Like Peptide-1 Receptor Agonists, Gastric Emptying, Hypoglycemic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Objectives
Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) are commonly used for diabetes management and are associated with delayed gastric emptying, raising concerns about an increased risk of retained gastric contents (RGC) during esophagogastroduodenoscopy (EGD). While this association has been investigated in Western populations, limited data are available for Asian populations.
Methods
We conducted a retrospective study involving 1324 patients with diabetes who underwent screening EGD between January 2020 and December 2023. Propensity score matching was used to compare 148 patients receiving GLP‐1 RA with 148 patients not receiving GLP‐1 RA. We evaluated the relationship between GLP‐1 RA use and the incidence of RGC during EGD.
Results
RGC occurred more frequently in the GLP‐1 RA group compared to the non‐GLP‐1 RA group, both before (12.0% vs. 3.7%, p < 0.001) and after matching (12.2% vs. 3.4%, p = 0.009). The association between GLP‐1 RA use and RGC remained consistent in subgroup analyses, including patients without a history of peptic ulcer scars or endoscopic treatment as well as those not receiving DPP‐4 inhibitors. Repeated EGD procedures were more frequent in the GLP‐1 RA group; however, no cases of aspiration pneumonia after EGD were observed.
Conclusions
The use of GLP‐1 RA in patients with diabetes significantly increases the risk of RGC during EGD in Asian populations. Implementing precautions, such as recommending a liquid diet the day before EGD, may help mitigate this risk in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Next-Generation Endoscopic Computer Vision, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Hiroyuki Hisada, Yuko Miura, Naomi Kakushima, Mitsuhiro Fujishiro
Zitieren
APA
Hisada, H., Tsuji, Y., Kubota, D., Miura, Y., Mizutani, H., Ohki, D., Yakabi, S., Takeuchi, C., Kakushima, N., Yamamichi, N., & Fujishiro, M. (2025). Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Retained Gastric Contents During Esophagogastroduodenoscopy: A Propensity Score‐Matched Study. Digestive Endoscopy. https://doi.org/10.1111/den.70016
Vancouver
Hisada H, Tsuji Y, Kubota D, Miura Y, Mizutani H, Ohki D, et al. Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Retained Gastric Contents During Esophagogastroduodenoscopy: A Propensity Score‐Matched Study. Digestive Endoscopy. 2025. doi:10.1111/den.70016
BibTeX
@article{Hisada2025,
author = {Hisada, Hiroyuki and Tsuji, Yosuke and Kubota, Dai and Miura, Yuko and Mizutani, Hiroya and Ohki, Daisuke and Yakabi, Seiichi and Takeuchi, Chihiro and Kakushima, Naomi and Yamamichi, Nobutake and Fujishiro, Mitsuhiro},
title = {Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Retained Gastric Contents During Esophagogastroduodenoscopy: A Propensity Score‐Matched Study},
journal = {Digestive Endoscopy},
year = {2025},
doi = {10.1111/den.70016}
}
EUVIMED